A comparison of direct thrombin inhibitors in the treatment of heparin-induced thrombocytopenia: a single institution experience


Background and objective Heparin-Induced Thrombocytopenia (HIT), if left untreated, can lead to thrombocytopenia, thromboembolic complications and even death. Two thrombin inhibitors, lepirudin and argatroban, have been shown to improve clinical outcomes compared to historical controls in the management of HIT. The purpose of this retrospective study was to… (More)
DOI: 10.1007/s11239-008-0275-1


3 Figures and Tables

Slides referencing similar topics